Luxembourg vs Western Europe: Proportion of the target population who received a 3rd dose of
Luxembourg
97.0%
in 2024
Western Europe
82.0%
in 2024
Luxembourg rank
11th
Western Europe rank
11th
Proportion of the target population who received a 3rd dose of over time
- Luxembourg
- Western Europe
How they compare
Luxembourg currently reports 97.0% against 82.0% in Western Europe, a difference of 15.0%.
That makes Luxembourg's figure about 1.2 times Western Europe's.
Across all 17 years both countries report, Luxembourg has been ahead every year.
Luxembourg ranks 11th and Western Europe ranks 11th of 157 countries.
Luxembourg has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Luxembourg | Western Europe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.0% | 31.5% | 54.5% | Luxembourg |
| 2010s | 93.4% | 82.5% | 10.9% | Luxembourg |
| 2020s | 96.6% | 83.0% | 13.6% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Luxembourg or Western Europe?
- Luxembourg, at 97.0% against 82.0% in Western Europe as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Luxembourg and Western Europe?
- 15.0%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and Western Europe?
- 17 years are reported by both, from 2008 to 2024.
- How do Luxembourg and Western Europe rank globally for proportion of the target population who received a 3rd dose of?
- Luxembourg ranks 11th and Western Europe ranks 11th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.